GridAI Technologies Corp. (GRDX)
Last updated: 2026-10-22 07:19:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
GridAI Technologies Corp. (GRDX) operates in the ELECTRIC & OTHER SERVICES COMBINED sector and is listed on NASDAQ. The stock is currently priced at $4.92, with a market capitalization of $33.02M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.87 to $6.93. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$33.02M | |
$4.55 | |
$6.93 | |
$1.87 | |
$4.63 | |
76.64K | |
112.18K | |
-- | |
$6.93 | |
$1.87 | |
-- | |
-- |
GridAI Technologies Corp. (GRDX) Latest Closing Stock Price
GridAI Technologies Corp. (GRDX) last closed at $4.63 as of 2026-10-21 23:50:00, unchanged from the previous close of $4.63.
During the latest regular trading session, GRDX traded between $1.87 and $6.93, with a volume of 76.64K shares. The closing price was near the middle and near the middle of its 52-week range.
GridAI Technologies Corp. (GRDX) 7-Day Stock Price Change
Over the past seven days, GridAI Technologies Corp. (GRDX) moved from $4.55 to $4.92, representing a gain of 8.07% ($0.37).
The stock traded between $4.14 and $5.26 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 94.65 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
GRDX 52-Week Price Position
Position in Range: 60.2%
GRDX is currently trading at $4.92, placing it 60.2% of the way from its 52-week low of $1.87 to its 52-week high of $6.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is GridAI Technologies Corp. (GRDX)?
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
GridAI Technologies Corp. Information
| Industry | ELECTRIC & OTHER SERVICES COMBINED |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy GridAI Technologies Corp. (GRDX) Stock on MEXC
Eligible investors can buy real shares of GridAI Technologies Corp. (GRDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is GridAI Technologies Corp. (GRDX) stock price today?
2.Is GRDX stock going up or down today?
3.What is GRDX pre-market price?
4.What is GRDX after-hours price?
5.Is GRDX stock trading now?
6.Where does GRDX sit relative to its 52-week high and low?
7.What sector is GridAI Technologies Corp. in?
8.What is GridAI Technologies Corp.'s market capitalization and where is it listed?
9.How is GRDX valued in terms of P/E ratio and EPS?
10.Does GridAI Technologies Corp. pay a dividend?
Explore More US Stocks
Search Stocks
GRDX Stock Calculator
Estimate the value between GRDX shares and USD.
GRDX Shares to USD
1.00 GRDX shares = 4.917 USD
Calculations are estimates based on the latest available price and are for reference only.


